CVS profit beats estimates on strong performance of pharmacy operations
CVS Health Corp beat Wall Street estimates for quarterly profit on Wednesday as strength in its drugstores and pharmacy benefit management business offset higher-than-expected medical costs at its ...
CVS results top expectations, lifted by strong health services revenue
The results come on the last day of a nationwide walkout by pharmacy staff from CVS, Walgreens and Rite Aid to protest what they call harsh working conditions.
Pharma Giant Prepares for Earnings Call
Pharmaceutical concern CVS Health Corp (NYSE:CVS) will enter the earnings confessional before the open tomorrow.
FDA warns against use of two-dozen eye drop products sold at CVS, Rite Aid over risk of infection and vision loss
The FDA is telling consumers to avoid two dozen eye drop products sold at major retailers including CVS and Rite Aid, because they could cause eye infections and potentially lead to vision loss.
CVS, Walgreens workers plan 3-day walkout
Walgreens (WBA) and CVS Health (CVS) workers are the newest batch of health care workers to threaten strikes against employers. Yahoo Finance Health Reporter Anjalee Khemlani details the demands in...
CVS, Target and other eye-drop products pose risk of dangerous infections, FDA warns
More than two dozen over-the-counter eye-drop products marketed under CVS Health Corp. CVS, +1.40%, Target Corp. TGT, +1.15%, Rite Aid Corp. RADCQ, +8.91% and other brands pose a risk of eye infect...
Strike Alert 2023: Workers at CVS, Walgreens, Rite Aid Walk Out
Workers at pharmacy companies CVS (NYSE: CVS ), Walgreens (NASDAQ: WBA ) and RiteAid (OTCMKTS: RADCQ ) have staged a strike that has them walking out on the businesses for three days to highlight w...
CVS, Walgreens Pharmacists Could Walk Off Job
Thousands of pharmacists at CVS and Walgreens could go on strike in an effort to improve working conditions and staffing levels. Shane Jerominski is an independent pharmacist.
CVS Health could see another earnings surprise in 3Q: analysts
CVS Health Corp (NYSE:CVS) will report its third quarter 2023 financial results on November 1, with analysts calling for earnings per share (EPS) of $2.13, reflecting a year-over-year increase of j...
CVS to pull cold medicines deemed ineffective by FDA
CVS Health (CVS) announced on Thursday that it will begin to pull several common cold products after an advisory panel from the FDA ruled that the active ingredient, oral phenylephrine, was ineffec...
CVS Health: Rite Aid's Chapter 11 Provides Opportunity
CVS Health can derive strong synergy benefits from their pharmacies, health insurance, and PBM businesses. CVS Health's debt load is manageable and offers the opportunity to acquire a number of Rit...
CVS Health: A Bargain Long-Term Opportunity
CVS Health's shares have not changed much over the past five years. The company is a leader in a sector that currently appears to be undervalued. Valuation suggests the company's intrinsic value li...
CVS Health: 'Only' A Fair Company For A Wonderful Price?
CVS Health: 'Only' A Fair Company For A Wonderful Price?
CVS Health to remove cough medicines due to effectiveness doubts
CVS Health said yesterday it is to remove oral cough and cold products with phenylephrine as the only active ingredient from its shelves following growing concerns over the drug's effectiveness. Ph...
CVS pulls popular cold medicines from store shelves
CVS said on Thursday that it is voluntarily removing certain common oral cough and cold products after a Food and Drug Administration (FDA) advisory panel determined last month that its active ingr...
Related Companies